Identification and prediction of promiscuous aggregating inhibitors among known drugs

Journal of Medicinal Chemistry

Volumn 46, Issue 21, 2003, Pages 4477-4486

  Seidler, James ^a   McGovern, Susan L ^a   Doman, Thompson N ^b   Shoichet, Brian K ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; AZELAIC ACID; BENZYL BENZOATE; BETA LACTAMASE; CARBAMAZEPINE; CARISOPRODOL; CHLORAMBUCIL; CHLORTALIDONE; CHYMOTRYPSIN; CINOXACIN; CLOTRIMAZOLE; DEFEROXAMINE MESYLATE; DELAVIRDINE; DIFLUNISAL; DIPHENHYDRAMINE; ECONAZOLE; ETODOLAC; FLUCONAZOLE; FLUTAMIDE; FUROSEMIDE; GEMFIBROZIL; GUAIFENESIN; KETOCONAZOLE; MALATE DEHYDROGENASE; MESALAZINE; MICONAZOLE; NICARDIPINE; SULCONAZOLE; SULFONE DERIVATIVE; UNINDEXED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG IDENTIFICATION; DRUG SPECIFICITY; ENZYME INHIBITION; LIGHT SCATTERING; STRUCTURE ACTIVITY RELATION;

ANTIFUNGAL AGENTS; BETA-LACTAMASES; CHEMISTRY, PHYSICAL; CHYMOTRYPSIN; ENZYME INHIBITORS; KINETICS; LIGHT; MALATE DEHYDROGENASE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SCATTERING, RADIATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0141923641     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030191r     Document Type: Article

References (34)

1. McGovern, S. L.; Caselli, E.; Grigorieff, N.; Shoichet, B. K. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 2002, 45, 1712-1722.
2. Roche, O.; Schneider, P.; Zuegge, J.; Guba, W.; Kansy, M.; Alanine, A.; Bleicher, K.; Danel, F.; Gutknecht, E. M.; Rogers-Evans, M.; Neidhart, W.; Stalder, H.; Dillon, M.; Sjogren, E.; Fotouhi, N.; Gillespie, P.; Goodnow, R.; Harris, W.; Jones, P.; Taniguchi, M.; Tsujii, S.; von Der Saal, W.; Zimmermann, G.; Schneider, G. Development of a Virtual Screening Method for Identification of "Frequent Hitters" in Compound Libraries. J. Med. Chem. 2002, 45, 137-142.
3. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 1997, 23, 3-25.
4. Muegge, I.; Heald, S. L.; Brittelli, D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 2001, 44, 1841-1846.
5. Frimurer, T. M.; Bywater, R.; Naerum, L.; Lauritsen, L. N.; Brunak, S. Improving the odds in discriminating "drug-like" from "non drug-like" compounds. J. Chem. Inf. Comput. Sci. 2000, 40, 1315-1324.
6. Xu, J.; Stevenson, J. Drug-like index: a new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci. 2000, 40, 1177-1187.
7. Oprea, T. I. Property distribution of drug-related chemical databases. J. Comput.-Aided Mol. Des. 2000, 14, 251-264.
8. Bajorath, J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discovery 2002, 1, 882-894.
9. Rishton, G. M. Reactive compounds and in vitro false positives in HTS. Drug Discovery Today 1997, 2, 382-384.
10. McGovern, S. L.; Shoichet, B. K. Kinase Inhibitors: Not Just for Kinases Anymore. J. Med. Chem. 2003, 46, 1478-1483.
11. Powers, R. A.; Morandi, F.; Shoichet, B. K. Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase. Structure (Camb) 2002, 10, 1013-1023.
12. Doman, T. N.; Cibulskis, J. M.; Cibulskis, M. J.; McCray, P. D.; Spangler, D. P. Algorithm5: A Technique for Fuzzy Similarity Clustering of Chemical Inventories. J. Chem. Inf. Comput. Sci. 1996, 36, 1195-1204.
13. Gao, H.; Shanmugasundaram, V.; Lee, P. Estimation of Aqueous Solubility of Organic Compounds with QSPR Approach. Pharm. Res. 2002, 19, 497-503.
14. Hawkins, D. M.; Young, S. S.; Rusinko, A. I. Analysis of Large Structure-Activity Data Set Using Recursive Partitioning. Quant. Struct.-Act. Relat. 1997, 16, 296-302.
15. Cerius-2; 4.2 ed.; Accelrys, Inc., San Diego.
16. Daylight Toolkit; Daylight Chemical Information Systems, Mission Viejo.
17. ACD/Labs; Advanced Chemistry Development Inc., Toronto.
18. QikProp; 2.0 ed.; Schrödinger, Inc., New York City.
19. Hall, L. H.; Kier, L. B. Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information. J. Chem. Inf. Comput. Sci. 1995, 35, 1039-1045.
20. http://mosbysdrugconsult.com/DrugConsult/Top_200/; Mosby's Drug Consult.
21. http://www.fda.gov/cder/orange/obreadme.htm; FDA Orange Book.
22. Camerman, A.; Camerman, N. Stereochemical Basis of Anticonvulsant Drug Action. II. Molecular Structure of Diazepam. J. Am. Chem. Soc. 1972, 94, 268-272.
23. Weston, G. S.; Blazquez, J.; Baquero, F.; Shoichet, B. K. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J. Med. Chem. 1998, 41, 4577-4586.
24. Barone, R.; Chanon, M. A New and Simple Approach to Chemical Complexity. Application to the Synthesis of Natural Products. J. Chem. Inf. Comput. Sci. 2001, 41, 269-272.
25. Ertl, P.; Rohde, B.; Selzer, P. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties. J. Med. Chem. 2000, 43, 3714-3717.
26. Molinoff, P.; Ruddon, R. Goodman's and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J., Limbird, L., Eds.; McGraw-Hill: 1996.
27. Sawyer, P.; Brogden, R.; Pinder, R.; Speight, T.; Avery, G. Clotrimazole: A Review of its Antifungal Activity and Therapeutic Efficacy. Drugs 1975, 9, 424-447.
28. Walton, S.; Myerscough, M.; Currie, B. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans. R. Soc. Trop. Med. Hyg. 2000, 94, 92-96.
29. Roche Laboratories Cardene (nicardipine hydrochloride) capsules: Complete Product Information; Roche, 1999.
30. Barry, M.; Mulcahy, F.; Merry, C.; Gibbons, S.; Back, D. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin. Pharm. 1999, 36, 289-304.
31. PDR Electronic Library; Thomson MICROMEDEX, 2002.
32. Pharmacia Glynase PresTab: Micronized Glyburide Tablets; Pharmacia, 2002.
33. Chiang, S.; Knowles, J.; Hubsher, J.; Ruelius, H.; Walker, B. Effects of Food on Oxaprozin Bioavailability. J. Clin. Pharm. 1984, 24, 381-385.
34. Stopa, B.; Gorny, M.; Konieczny, L.; Piekarska, B.; Rybarska, J.; Skowronek, M.; Roterman, I. Supramolecular ligands: monomer structure and protein ligation capability. Biochimie 1998, 80, 963-968.